Circle Pharma
Eric Connor, PhD, PMP, is a seasoned professional in the field of chemistry with extensive experience in small molecule CMC (Chemistry, Manufacturing, and Controls). Currently serving as Senior Director of Small Molecule CMC at Circle Pharma, Inc. since August 2023, Eric previously held similar roles at Boundless Bio and Arcus Biosciences, where innovative anti-cancer therapies were developed. Eric also contributed to the drug development efforts at MyoKardia, Tricida, Relypsa, Ilypsa, and Symyx Technologies, advancing from roles such as Chemistry Fellow and Associate Director to Senior Scientist. Eric's academic background includes a PhD from Caltech and a BSc from University College Dublin, complemented by postdoctoral research at the IBM Almaden Research Center.
This person is not in any offices
Circle Pharma
2 followers
Circle Pharma, Inc. initiated operations in June 2014 with seed funding from Pfizer, Inc. and Mission Bay Capital, LLP; we received additional seed funding from ShangPharma Investment Group Limited in November 2015. We recently raised Series B and Series C financing from The Column Group and NextTech Invest.